{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:06:16Z","timestamp":1770231976802,"version":"3.49.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.03097","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T05:56:20Z","timestamp":1580190980000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations"],"prefix":"10.3389","volume":"10","author":[{"given":"Anna S.","family":"\u015awierzko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Soko\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Szala-Po\u017adziej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Eppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Mitrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Szmigielska-Kap\u0142on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Sobczyk-Kruszelnicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Go\u0142os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Wierzbowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Giebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Jamroziak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek L.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Brzezi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misao","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens C.","family":"Jensenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Gajek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Cedzy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1006\/geno.1996.0497","article-title":"Cloning and characterization of the human lectin P35 gene and its related gene","volume":"36","author":"Endo","year":"1996","journal-title":"Genomics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1074\/jbc.271.5.2448","article-title":"A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin","volume":"271","author":"Matsushita","year":"1996","journal-title":"J Biol Chem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20721","DOI":"10.1074\/jbc.273.33.20721","article-title":"Cloning and characterization of the Hakata antigen, a member of the ficolin\/opsonin p35 lectin family","volume":"273","author":"Sugimoto","year":"1998","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/002215549904700607","article-title":"Hakata antigen, a new member of the ficolin\/opsonin p35 family, is a novel human lectin secreted into bronchus\/alveolus and bile","volume":"47","author":"Akaiwa","year":"1999","journal-title":"J Histochem Cytochem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.4049\/jimmunol.175.5.3150","article-title":"Human M-ficolin is a secretory protein that activates the lectin complement pathway","volume":"175","author":"Liu","year":"2005","journal-title":"J Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.molimm.2007.10.006","article-title":"Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen)","volume":"45","author":"Hummelshoj","year":"2008","journal-title":"Mol Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000218324","article-title":"Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma","volume":"2","author":"Wittenborn","year":"2010","journal-title":"J Innate Immun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/imr.12462","article-title":"Complement in removal of the dead \u2013 balancing inflammation","volume":"274","author":"Martin","year":"2016","journal-title":"Immun Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.it.2009.04.002","article-title":"Is complement good or bad for cancer patients?","volume":"30","author":"Markiewski","year":"2009","journal-title":"Trends Immunol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.4049\/jimmunol.156.12.4892","article-title":"Sublytic complement attack induces cell cycle in oligodendrocytes","volume":"156","author":"Rus","year":"1996","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1034\/j.1600-065X.2001.1800104.x","article-title":"Role of the C5b-9 complement complex in cell cycle and apoptosis","volume":"180","author":"Rus","year":"2001","journal-title":"Immunol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1385\/IR:31:1:37","article-title":"The role of C5b-9 terminal complement complex in activation of the cell cycle and transcription","volume":"31","author":"Fosbrink","year":"2005","journal-title":"Immunol Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.cellsig.2006.02.006","article-title":"CXCL12 and C5a trigger cell migration via a PAK1\/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway","volume":"18","author":"Rousseau","year":"2006","journal-title":"Cell Signal"},{"key":"B14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00011-010-0220-6","article-title":"The complement cascade as a mediator of tissue growth and regeneration","volume":"59","author":"Rutkowski","year":"2010","journal-title":"Inflamm Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1074\/jbc.M109.092106","article-title":"The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction","volume":"285","author":"Bamberg","year":"2010","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.imbio.2015.11.008","article-title":"The complement system in cancer: ambivalence between tumour destruction and promotion","volume":"222","author":"Mamidi","year":"2012","journal-title":"Immunobiology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopha.2017.04.101","article-title":"Recent progress in the understanding of complement activation and its role in tumor growth and anti-tumor therapy","volume":"91","author":"Liu","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3389\/fimmu.2018.01629","article-title":"Complementing cancer metastasis","volume":"9","author":"Kochanek","year":"2018","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1681\/ASN.2008040434","article-title":"C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy","volume":"20","author":"Tang","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1096\/fj.10-156083","article-title":"The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro","volume":"25","author":"Speidl","year":"2011","journal-title":"FASEB J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.4049\/jimmunol.1201654","article-title":"Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression","volume":"189","author":"Corrales","year":"2012","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1158\/1078-0432.CCR-12-1204","article-title":"Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88)","volume":"19","author":"Nitta","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cam4.241","article-title":"Complement anaphylatoxins as immune regulators in cancer","volume":"4","author":"Sayegh","year":"2014","journal-title":"Cancer Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1593\/neo.121262","article-title":"Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization","volume":"11","author":"Nunez-Cruz","year":"2012","journal-title":"Neoplasia."},{"key":"B25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/leu.2016.278","article-title":"Novel evidence that the mannan-binding lectin pathway of complement activation plays a pivotal role in triggering mobilization of hematopoietic stem\/progenitor cells by activation of both the complement and coagulation cascades","volume":"31","author":"Adamiak","year":"2017","journal-title":"Leukemia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2016.05.007","article-title":"FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-\u03b2\/Smad signaling","volume":"378","author":"Yang","year":"2016","journal-title":"Cancer Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clim.2017.08.012","article-title":"Ficolin-2 triggers antitumour effect by activating macrophages and CD8+ T cells","volume":"183","author":"Ding","year":"2017","journal-title":"Clin Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1038\/srep07824","article-title":"A novel IgM-H-ficolin complement pathway to attack allogenic cancer cells","volume":"5","author":"Lei","year":"2015","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.imbio.2019.01.002","article-title":"Interactions of ficolin-3 with ovarian cancer cells","volume":"224","author":"Michalski","year":"2019","journal-title":"Immunobiology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2015045","DOI":"10.4084\/mjhid.2015.045","article-title":"Bacterial infections in hematopoietic stem cell transplant recipients","volume":"7","author":"Balletto","year":"2015","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3389\/fmicb.2018.02317","article-title":"Infection complications in hematopoietic stem cells transplant recipients: do genetics really matter?","volume":"9","author":"Luis Espinoza","year":"2018","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.hemonc.2017.05.005","article-title":"Recent advances in understanding multiple myeloma","volume":"10","author":"Hari","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ajh.24402","article-title":"Multiple myeloma","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Am J Hematol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.clml.2018.12.010","article-title":"Hematopoietic progenitor cell mobilization for autologous stem cell transplantation in multiple myeloma in contemporary era","volume":"19","author":"Arora","year":"2019","journal-title":"Clin Lymph Myeloma Leuk."},{"key":"B35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mpmed.2017.02.008","article-title":"Non-Hodgkin lymphoma","volume":"45","author":"Ninkovic","year":"2017","journal-title":"Medicine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3322\/caac.21438","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e50585","DOI":"10.1371\/journal.pone.0050585","article-title":"Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin","volume":"7","author":"Ammitzb\u00f8ll","year":"2012","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/hmg\/ddi173","article-title":"Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2","volume":"14","author":"Hummelshoj","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2249.2007.03471.x","article-title":"Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene","volume":"150","author":"Cedzynski","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.humimm.2013.04.011","article-title":"The relationship between FCN2 genotypes and serum ficolin-2 (L-ficolin) protein concentrations from a large cohort of neonates","volume":"74","author":"Kilpatrick","year":"2013","journal-title":"Hum Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1056\/NEJMoa0900381","article-title":"Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency","volume":"360","author":"Munthe-Fog","year":"2009","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.3389\/fimmu.2018.02153","article-title":"The role of complement activating collectins and associated serine proteases in patients with hematological malignancies, receiving high-dose chemotherapy, and autologous hematopoietic stem cell transplantations (auto-HSCT)","volume":"9","author":"Swierzko","year":"2018","journal-title":"Front Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.imbio.2016.01.003","article-title":"Components of the lectin pathway of complement activation in paediatric patients of intensive care units","volume":"221","author":"Swierzko","year":"2016","journal-title":"Immunobiology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1101\/gr.2754005","article-title":"novoSNP, a novel computational tool for sequence variation discovery","volume":"15","author":"Weckx","year":"2005","journal-title":"Genome Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00251-013-0696-7","article-title":"Cost-effective procedures for genotyping of human FCN2 gene single nucleotide polymorphisms","volume":"65","author":"Szala","year":"2013","journal-title":"Immunogenetics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.imbio.2011.12.004","article-title":"H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates","volume":"217","author":"Michalski","year":"2012","journal-title":"Immunobiology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.imbio.2010.09.013","article-title":"M-ficolin in children with cancer","volume":"216","author":"Schlapbach","year":"2011","journal-title":"Immunobiology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2249.2011.04512.x","article-title":"M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy","volume":"167","author":"Ameye","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1365-2249.2003.02284.x","article-title":"No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections","volume":"143","author":"Kilpatrick","year":"2003","journal-title":"Clin Exp Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/pbc.24951","article-title":"Mannose-binding lectin and ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia","volume":"61","author":"Pana","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1182\/blood-2016-08-735324","article-title":"Plasma biomarkers of risk for death in a multicentre phase 3 trial with uniform transplant characteristics post-allogenic HCT","volume":"129","author":"Abu Zaid","year":"2017","journal-title":"Blood."},{"key":"B54","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4274\/tjh.2014.0385","article-title":"Early changes of mannose-binding lectin, H-ficolin, and procalcitonin in patients with febrile neutropenia: a prospective observational study","volume":"33","author":"Islak Mutcali","year":"2016","journal-title":"Turk J Hematol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2249.2009.03957.x","article-title":"H-ficolin serum concentration and susceptibility to fever and neutropenia in paediatric cancer patients","volume":"157","author":"Schlapbach","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/cei.12909","article-title":"Lectin complement pathway proteins in healthy individuals","volume":"188","author":"Troldborg","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.molimm.2013.05.233","article-title":"Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures","volume":"56","author":"Hein","year":"2013","journal-title":"Mol Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/CVI.00607-13","article-title":"Blood collection tubes influence serum ficolin-1 and ficolin-2 levels","volume":"21","author":"Brady","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e2705","DOI":"10.7717\/peerj.2705","article-title":"Ficolin-2 inhibitors are present in sera after prolonged storage at\u221280\u00b0C","volume":"4","author":"Geno","year":"2016","journal-title":"Peer J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.03097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T19:57:11Z","timestamp":1695671831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.03097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2019.03097"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.03097","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"article-number":"3097"}}